PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy. Electronic address: david.pinato@imperial.ac.uk.\', \'Unit of Cancer Epidemiology, Department of Translational Medicine, CPO-Piemonte, University of Piemonte Orientale, Novara, Italy.\', \'Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.\', \'Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, 114 Rue Edouard Vaillant, 94800, Villejuif, France.\', \'Medical Oncology, Guy\'s and St Thomas\' NHS Foundation Trust (GSTT), London, UK.\', \'Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.\', \'Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK; Medical Oncology, Velindre Cancer Centre, Cardiff, UK.\', \'Medical Oncology, Barts Health NHS Trust, London, UK.\', \'Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.\', \'Medical Oncology, Vall d\'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain; Infectious Diseases, Vall d\'Hebron University Hospital, Barcelona, Spain.\', \'Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.\', \'Cancer Division, University College London Hospitals, London, UK.\', \'Department of Medical Oncology, ICO L\'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Spain.\', \'Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089, Milan, Italy.\', \'Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.\', \'Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain.\', \'Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.\', \'Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Italy; Department of Medical, Surgical and Health Sciences, University of Trieste, Italy.\', \'Medical Oncology Unit, Spedali Civili, Brescia, Italy.\', \'Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.\', \'Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.\', \'Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King\'s College London, London, UK.\', \'Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK.\', \'Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany.\', \'Policlinico Universitario Campus Bio-Medico, Rome, Italy.\', \'Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.\', \'Medical Oncology, Vall d\'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.\', \'Department of Internal Medicine, Hospital Clinic, Barcelona, Spain.\', \'Infectious Diseases, Vall d\'Hebron University Hospital, Barcelona, Spain.\', \'Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy.\', \'Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain.\', \'Fundació Althaia Manresa, Manresa, Spain.\', \'Hospital Universitario XII de Octubre Madrid, Spain.\', \'Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 20090 Pieve Emanuele, Milan, Italy; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089, Milan, Italy.\', \'Division of Radiotherapy, Department of Translational Medicine, University of Piemonte Orientale and Azienda Ospedaliera Maggiore Della Carita, Novara, Italy.\', \'Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.\', \'Medical Oncology, Vall d\'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain.\', \'Medical Oncology, Guy\'s and St Thomas\' NHS Foundation Trust (GSTT), London, UK; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King\'s College London, London, UK.\', \'Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK; Department of Biotechnology and Applied Clinical Sciences, University of L\'Aquila, Via Vetoio, 67100, L\'Aquila, Italy. Electronic address: a.cortellini@imperial.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0959-8049(21)00202-110.1016/j.ejca.2021.03.035
?:doi
?:hasPublicationType
?:journal
  • European journal of cancer (Oxford, England : 1990)
is ?:pmid of
?:pmid
?:pmid
  • 33932726
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all